cueprepNCLEX-RN Checkpoint Inhibitors & Immune-Related Adverse Effects Flashcards
Master 4 checkpoint inhibitors & immune-related adverse effects concepts for the NCLEX-RN.
Question
What is the primary mechanism of action (MOA) of checkpoint inhibitors like nivolumab and pembrolizumab?
Question
Which group of adverse effects is most characteristic of immune checkpoint inhibitors, distinguishing them from traditional chemotherapy?
Question
Select the correct interventions for managing immune-related adverse effects:
Management of moderate-to-severe irAEs involves the checkpoint inhibitor and administering systemic .
Question
What 4 specific signs/symptoms should a nurse teach a patient on checkpoint inhibitors to report immediately?